TerminatedNot Applicable

Telehealth-Supervised Resistance Training for Children With Cerebral Palsy

Stopped: The study was terminiated due to funding.

China50 participantsStarted 2026-01-01

Plain-language summary

The goal of this clinical trial is to evaluate the feasibility and potential benefits of telehealth-supervised resistance training in ambulatory children aged 6 to 15 years with cerebral palsy (CP) classified as Gross Motor Function Classification System (GMFCS) levels I-III. The main questions it aims to answer are: * Is a 12-week telehealth-delivered resistance training program feasible and acceptable for children with CP and their caregivers? * Can the program improve physical function and psychosocial well-being in this population? Participants will: * Take part in three 40-minute, live-streamed resistance training sessions each week for 12 weeks, using elastic bands, sandbag weights, and balance tools * Complete physical assessments before and after the program, including the 1-minute walk test, 10-meter walk test, 30-second sit-to-stand test, and Pediatric Balance Scale * Complete quality of life surveys using the Pediatric Quality of Life Inventory (PedsQL™ 3.0 CP Module) * Have caregivers complete a custom questionnaire about the cost and acceptability of the program

Who can participate

Age range

6 Years – 15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * No history of heart disease or family history of heart disease; * Children classified as GMFCS levels I, II, or III; * Dependent on assistive mobility devices, such as wheelchairs or posture support walkers, for activities of daily living; * Medically stable and able to sit upright for at least 30 minutes; * Able to understand simple verbal or visual instructions. Exclusion Criteria: * Aged under 6 years or over 15 years; * Received botulinum toxin A injections for lower limb muscles within six months prior to baseline assessment; * Implanted with an intrathecal baclofen pump, or has a history of lower limb-related orthopedic or neurosurgical interventions (such as tendon lengthening, osteotomy, or selective dorsal rhizotomy); * Has uncontrolled epilepsy, severe cognitive impairment, or other comorbidities.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

1-minute walk test

Timeframe: Baseline (week 0) and post-intervention (week 12)

10-meter walk test

Timeframe: Baseline (week 0) and post-intervention (week 12)

Lower-limb muscle strength

Timeframe: Baseline (week 0) and post-intervention (week 12)

Balance

Timeframe: Baseline (week 0) and post-intervention (week 12)

Pediatric Quality of Life Inventory

Timeframe: Baseline (week 0) and post-intervention (week 12)

Trial details

NCT IDNCT07061275

SponsorHunan Normal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-01

View on ClinicalTrials.gov More Cerebral Palsy trials

Plain-language summary

Who can participate

Age range

6 Years – 15 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

1-minute walk test

Timeframe: Baseline (week 0) and post-intervention (week 12)

10-meter walk test

Timeframe: Baseline (week 0) and post-intervention (week 12)

Lower-limb muscle strength

Timeframe: Baseline (week 0) and post-intervention (week 12)

Balance

Timeframe: Baseline (week 0) and post-intervention (week 12)

Pediatric Quality of Life Inventory

Timeframe: Baseline (week 0) and post-intervention (week 12)